NCT05753033View on ClinicalTrials.gov

The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

September 6, 2023

Study Completion Date

September 6, 2023

Conditions
Healthy
Interventions
DRUG

SR750 tablet

Ascending single and multiple doses of SR750 orally

DRUG

Placebo

Ascending single and multiple doses of placebo orally

Trial Locations (1)

Unknown

Shanghai Clinical Research Center Phase I Clinical Research Unit (SCRC-PCRU), Shanghai

All Listed Sponsors
lead

Shanghai SIMR Biotechnology Co., Ltd.

INDUSTRY